What is the address of Dr. Ann Langedock, Gynaecologie?

The registered office of Dr. Ann Langedock, Gynaecologie is located at Kampstraat(Kor) 1, 8500 Kortrijk.

Is Dr. Ann Langedock, Gynaecologie still active?

Yes. According to the CBE (19 September 2026) Dr. Ann Langedock, Gynaecologie is active, legal situation “Normale toestand”, started on 24 August 2020.

Is Dr. Ann Langedock, Gynaecologie registered on Peppol?

Yes, Dr. Ann Langedock, Gynaecologie is registered on the Peppol network with ID 0208:0752870547.

What is the enterprise number of Dr. Ann Langedock, Gynaecologie?

The enterprise number of Dr. Ann Langedock, Gynaecologie is BE0752870547.

When was Dr. Ann Langedock, Gynaecologie founded?

Dr. Ann Langedock, Gynaecologie was founded on 24 August 2020.

Who are the directors of Dr. Ann Langedock, Gynaecologie?

According to the 2025 annual accounts, the directors of Dr. Ann Langedock, Gynaecologie are: Ann Langedock.

Is Dr. Ann Langedock, Gynaecologie a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 24 August 2020; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did Dr. Ann Langedock, Gynaecologie make in 2025?

Dr. Ann Langedock, Gynaecologie posted a profit after taxes of € 166,721 in financial year 2025.

What is the revenue of Dr. Ann Langedock, Gynaecologie?

As a small company, Dr. Ann Langedock, Gynaecologie is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 215,009.

Dr. Ann Langedock, Gynaecologie (Private Limited)

Dossier Dr. Ann Langedock, Gynaecologie, printed on 19 September 2026 from databakkes.be/en/0752870547/dr-ann-langedock-gynaecologie. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

Dr. Ann Langedock, Gynaecologie from Kortrijk, company number BE0752870547, closed financial year 2025 with a result of € 166,721 after tax. For that financial year Dr. Ann Langedock, Gynaecologie recorded a gross margin of € 215,009 and equity of € 252,541. Compared with financial year 2024, the result moved from € 131,282 to € 166,721. Profitable, and profit is growing. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on April 28, 2026.

What it is worth Healthy

€ 252,541

▼ 34% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 166,721

▲ 27% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 171,331

▼ 35% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 294,003 paid out

More than the year’s profit went to the shareholders; reserves fell.

People and assets in 2025

Full-time equivalents estimate The annual accounts report no full-time equivalents. A micro company with one active director is usually run by that person; this is an assumption, not a figure from the source.

≈ 1

No payroll staff. One director, so that person most likely runs the business.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Taxes

€ 10,548

▲ 273% vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 145,610 Gross margin 2022: € 145,610 First fiscal year in the series	€ 161,816 Gross margin 2023: € 161,816 ▲ 11% vs 2022 (€ 145,610) Favourable step	€ 170,092 Gross margin 2024: € 170,092 ▲ 5% vs 2023 (€ 161,816) Favourable step	€ 215,009 Gross margin 2025: € 215,009 ▲ 26% vs 2024 (€ 170,092) Favourable step	▲ 26%
Profit after taxes	€ 112,535 Profit after taxes 2022: € 112,535 First fiscal year in the series	€ 124,398 Profit after taxes 2023: € 124,398 ▲ 11% vs 2022 (€ 112,535) Favourable step	€ 131,282 Profit after taxes 2024: € 131,282 ▲ 6% vs 2023 (€ 124,398) Favourable step	€ 166,721 Profit after taxes 2025: € 166,721 ▲ 27% vs 2024 (€ 131,282) Favourable step	▲ 27%
Equity	€ 124,142 Equity 2022: € 124,142 First fiscal year in the series	€ 248,540 Equity 2023: € 248,540 ▲ 100% vs 2022 (€ 124,142) Favourable step	€ 379,822 Equity 2024: € 379,822 ▲ 53% vs 2023 (€ 248,540) Favourable step	€ 252,541 Equity 2025: € 252,541 ▼ 34% vs 2024 (€ 379,822) Unfavourable step	▼ 34%
Total debts	€ 16,610 Total debts 2022: € 16,610 First fiscal year in the series	€ 38,459 Total debts 2023: € 38,459 ▲ 132% vs 2022 (€ 16,610) Unfavourable step	€ 4,048 Total debts 2024: € 4,048 ▼ 89% vs 2023 (€ 38,459) Favourable step	€ 23,947 Total debts 2025: € 23,947 ▲ € 19,899 vs 2024 (€ 4,048) Unfavourable step	▲ € 19,899
Cash	€ 83,245 Cash 2022: € 83,245 First fiscal year in the series	€ 239,580 Cash 2023: € 239,580 ▲ 188% vs 2022 (€ 83,245) Favourable step	€ 264,918 Cash 2024: € 264,918 ▲ 11% vs 2023 (€ 239,580) Favourable step	€ 171,331 Cash 2025: € 171,331 ▼ 35% vs 2024 (€ 264,918) Unfavourable step	▼ 35%
Retained profit	€ 119,142 Retained profit 2022: € 119,142 First fiscal year in the series	€ 243,540 Retained profit 2023: € 243,540 ▲ 104% vs 2022 (€ 119,142) Favourable step	€ 374,822 Retained profit 2024: € 374,822 ▲ 54% vs 2023 (€ 243,540) Favourable step	€ 247,541 Retained profit 2025: € 247,541 ▼ 34% vs 2024 (€ 374,822) Unfavourable step	▼ 34%
Dividend	€ 0 Dividend 2022: € 0 First fiscal year in the series	€ 0 Dividend 2023: € 0 Unchanged (€ 0) Unchanged	€ 0 Dividend 2024: € 0 Unchanged (€ 0) Unchanged	€ 294,003 Dividend 2025: € 294,003 Unchanged (€ 0) Unchanged
Balance sheet total	€ 140,752 Balance sheet total 2022: € 140,752 First fiscal year in the series	€ 286,999 Balance sheet total 2023: € 286,999 ▲ 104% vs 2022 (€ 140,752) Unchanged	€ 383,870 Balance sheet total 2024: € 383,870 ▲ 34% vs 2023 (€ 286,999) Unchanged	€ 276,488 Balance sheet total 2025: € 276,488 ▼ 28% vs 2024 (€ 383,870) Unchanged	▼ 28%

Key figures of Dr. Ann Langedock, Gynaecologie, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 30 April 2027.

What happened to Dr. Ann Langedock, Gynaecologie?

What happened at Dr. Ann Langedock, Gynaecologie in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Apr 28, 2026 New annual accounts for financial year 2025: profit of € 166,721 (▲ 27% vs 2024). Source: NBB ↗
Aug 24, 2020 New establishment in Kortrijk. KBO
Aug 24, 2020 Start of the company according to the CBE. KBO

In short

From € 112,535 profit in 2022 to € 166,721 profit in 2025.

Paid € 153,920 in corporate taxes since 2022.

Best year ever: 2025, with € 166,721 profit.

Paid out € 294,003 in dividends to the owners in total.

Original PDFs at the National Bank ↗

A new publication or filing at Dr. Ann Langedock, Gynaecologie? We notify you, reason included.

Follow Dr. Ann Langedock, Gynaecologie

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Management

Ann Langedock

Dr. Ann Langedock, Gynaecologie

Behind Dr. Ann Langedock, Gynaecologie is Ann Langedock.

See the full network in the app

Directors

According to the 2025 annual accounts

Ann Langedock

Director

Establishments

Establishment units

Physical locations of this company

Registered office

Kampstraat(Kor) 1

8500 Kortrijk

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0752.870.547
VAT number: BE 0752.870.547
Registered office: Kampstraat(Kor) 1, 8500 Kortrijk
Names & denominations: Dr. Ann Langedock, Gynaecologie
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 24 August 2020
Peppol: Active · Active since 1 Jan 2001

View on CBE Public ↗ Annual accounts (NBB) ↗